GR900100179A - Στερεές φαρμακευτικές συν?έσεις και μέ?οδος για την παρασκευή τους. - Google Patents

Στερεές φαρμακευτικές συν?έσεις και μέ?οδος για την παρασκευή τους.

Info

Publication number
GR900100179A
GR900100179A GR900100179A GR900100179A GR900100179A GR 900100179 A GR900100179 A GR 900100179A GR 900100179 A GR900100179 A GR 900100179A GR 900100179 A GR900100179 A GR 900100179A GR 900100179 A GR900100179 A GR 900100179A
Authority
GR
Greece
Prior art keywords
ywxw
xwð
xæyμzzw
qxw
ñãáàñ
Prior art date
Application number
GR900100179A
Other languages
English (en)
Other versions
GR1002295B (el
Inventor
Erzsebet Barkzay
Margit Dr Csorgo
Sandor Dr Erdos
Marton Dr Fekete
Frigyes Dr Gorgenyi
Neetajthy Eva Juhasz
Jozsef Dr Kenderfi
Maria Krisztian
Attila Dr Mandi
Nee Hegedus Aranka Szima
Peter Dr Tompe
Zoltan Dr Torma
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10953380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR900100179(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of GR900100179A publication Critical patent/GR900100179A/el
Publication of GR1002295B publication Critical patent/GR1002295B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR900100179A 1989-03-14 1990-03-12 Στερεες φαρμακευτικες συνθεσεις και μεθοδος για την παρασκευη τους. GR1002295B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU891215A HU203041B (en) 1989-03-14 1989-03-14 Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin

Publications (2)

Publication Number Publication Date
GR900100179A true GR900100179A (el) 1991-07-31
GR1002295B GR1002295B (el) 1996-05-03

Family

ID=10953380

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100179A GR1002295B (el) 1989-03-14 1990-03-12 Στερεες φαρμακευτικες συνθεσεις και μεθοδος για την παρασκευη τους.

Country Status (20)

Country Link
US (1) US5108757A (el)
EP (1) EP0387782B2 (el)
JP (1) JPH02279626A (el)
AT (1) AT402889B (el)
BG (1) BG91467A (el)
CA (1) CA2012194C (el)
CH (1) CH680416A5 (el)
CY (1) CY1762A (el)
CZ (1) CZ277897B6 (el)
DD (1) DD294415A5 (el)
DE (1) DE59008160D1 (el)
FR (1) FR2644343B1 (el)
GB (1) GB2229095B (el)
GR (1) GR1002295B (el)
HK (1) HK218696A (el)
HU (2) HU203041B (el)
IT (1) IT1240605B (el)
RU (1) RU1837874C (el)
UA (1) UA19285A (el)
YU (1) YU47691B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
JP3220373B2 (ja) * 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
EP1202716A1 (en) * 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US6660303B2 (en) * 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
WO2003080057A1 (fr) * 2002-03-27 2003-10-02 Bayer Aktiengesellschaft Comprime-noyau de taille reduite contenant de la nifedipine
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US8128460B2 (en) * 2006-09-14 2012-03-06 The Material Works, Ltd. Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142561A1 (en) * 1981-09-14 1985-05-29 Kanebo, Ltd. Long-acting nifedipine preparation
WO1986001717A1 (en) * 1984-09-14 1986-03-27 Pharmatec S.P.A. Controlled release nifedipine preparation
EP0232155A2 (en) * 1986-02-03 1987-08-12 Elan Corporation Plc Drug delivery system
EP0267386A1 (de) * 1986-11-14 1988-05-18 Klinge Pharma GmbH Feste Arzneizubereitungen und Verfahren zu ihrer Herstellung
EP0274176A2 (en) * 1987-01-09 1988-07-13 ELAN CORPORATION, Plc Sustained release capsule or tablet formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
EP0207638B1 (en) * 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142561A1 (en) * 1981-09-14 1985-05-29 Kanebo, Ltd. Long-acting nifedipine preparation
WO1986001717A1 (en) * 1984-09-14 1986-03-27 Pharmatec S.P.A. Controlled release nifedipine preparation
EP0232155A2 (en) * 1986-02-03 1987-08-12 Elan Corporation Plc Drug delivery system
EP0267386A1 (de) * 1986-11-14 1988-05-18 Klinge Pharma GmbH Feste Arzneizubereitungen und Verfahren zu ihrer Herstellung
EP0274176A2 (en) * 1987-01-09 1988-07-13 ELAN CORPORATION, Plc Sustained release capsule or tablet formulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
DD294415A5 (de) 1991-10-02
US5108757A (en) 1992-04-28
CA2012194A1 (en) 1990-09-14
JPH02279626A (ja) 1990-11-15
BG91467A (bg) 1993-12-24
IT1240605B (it) 1993-12-17
YU47691B (sh) 1996-01-08
CZ277897B6 (en) 1993-06-16
ATA60690A (de) 1997-02-15
IT9019677A1 (it) 1991-09-14
EP0387782A3 (de) 1991-03-13
CA2012194C (en) 1995-10-31
GB2229095B (en) 1993-02-10
HK218696A (en) 1997-01-03
GB2229095A (en) 1990-09-19
CY1762A (en) 1994-07-15
FR2644343A1 (fr) 1990-09-21
HU203041B (en) 1991-05-28
EP0387782B2 (de) 1996-11-06
UA19285A (uk) 1997-12-25
AT402889B (de) 1997-09-25
HUT54046A (en) 1991-01-28
GR1002295B (el) 1996-05-03
DE59008160D1 (de) 1995-02-16
IT9019677A0 (it) 1990-03-14
EP0387782B1 (de) 1995-01-04
GB9005730D0 (en) 1990-05-09
HU211507A9 (en) 1995-11-28
RU1837874C (ru) 1993-08-30
FR2644343B1 (fr) 1994-10-21
CH680416A5 (el) 1992-08-31
EP0387782A2 (de) 1990-09-19
YU45890A (en) 1992-05-28

Similar Documents

Publication Publication Date Title
GR900100179A (el) Στερεές φαρμακευτικές συν?έσεις και μέ?οδος για την παρασκευή τους.
AU624735B2 (en) Enhanced blended and portland cement compositions
GR890100190A (el) Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν.
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
AU6487390A (en) Deodorizing and cleaning compositions and method
HUP0100562A3 (en) Spheroids method for their preparation and pharmaceutical compositions containing them
PL306079A1 (en) Pectins containing compositions and method of obtaining them
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
GR900100688A (en) Novel macrocyclic compositions and new application method thereof
PL306080A1 (en) Pectins containing compositions and method of obtaining them
AU6214590A (en) Stain-resistant plasticizer compositions and method of making same
ZW23287A1 (en) Synergistic herbicide compositions and method of application
GB8922701D0 (en) Compositions and methods for weight reduction
GR900100194A (el) Μέ?οδος και συσκευή αποστειρώσεως.
SG47129A1 (en) Preparation of spherical polyphenol particles
IL118382A (en) Substituted benzopyrans their preparation and pharmaceutical compositions containing them
AU1939488A (en) Method and compositions for making ACSF and ACSF antagonists
EP0445239A4 (en) Anti-malarial composition and method of use
AU3581397A (en) Slow release pharmaceutical compositions and methods of making same
GB8907656D0 (en) New compositions of matter
AU5350190A (en) Methods and compositions for the identification of patients sensitive to interferon alpha
GB8913865D0 (en) New compositions of matter
PL305939A1 (en) Prolonged release compositions and method of obtaining them
IE893997L (en) Compositions of hexahydro-5-pyrimidinamine and thymol
GB8922867D0 (en) Pharmaceutical method and compositions